Results 11 to 20 of about 1,266,459 (215)
Posttransplant Lymphoproliferative Disorders [PDF]
Advances in Hematology, 2012 Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations.
Hazem A. H. Ibrahim, Kikkeri N. Naresh
doaj +6 more sources
Anemia in Lymphoproliferative Disorders [PDF]
Cancer Control, 1998 The onset of anemia in patients with lymphoproliferative disorders can be attributed to various causes, including autoimmune hemolytic anemia, pure red cell aplasia, and anemia of chronic disease. A variety of interventions can provide benefit.
Thomas P. Loughran
openaire +3 more sources
Lymphoproliferative Disorders and Chemokines
Current Drug Targets, 2006 Chemokines are low molecular weight cytokines specialized in leukocyte recruitment. Recent studies have shown that tumor cells of hematopoietic and non hematopoietic origin express different chemokine receptors that may be involved in neoplastic cell growth, metastasis and angiogenesis.
PISTOIA V +3 more
openaire +3 more sources
Lymphoproliferative Disorders of the Lung [PDF]
Respiration, 2017 This review aims to describe some of the most frequent lymphoproliferative disorders arising from the lung: pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma, lymphomatoid granulomatosis (LG), multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and nodular lymphoid hyperplasia (NLH). Primary pulmonary lymphoma is defined as
Raphaël Borie +3 more
openaire +3 more sources
Ferroptosis in Lymphoproliferative Disorders
CellsFerroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and is mechanistically distinct from apoptosis, necrosis and pyroptosis.
Santino Caserta +12 more
doaj +2 more sources
Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract [PDF]
Haematologica, 2020 Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract are rare clonal T-cell diseases that more commonly occur in the intestines and have a protracted clinical course.
Craig R. Soderquist +15 more
doaj +3 more sources
Hemato, 2022 Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract are uncommon clonal neoplasms that have a protracted clinical course and limited response to therapy.
Craig R. Soderquist, Govind Bhagat
doaj +2 more sources
Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders [PDF]
Journal for ImmunoTherapy of Cancer, 2016 The T-cell lymphoproliferative disorders are a heterogeneous group of non-Hodgkin’s lymphomas (NHL) for which current therapeutic strategies are inadequate, as most patients afflicted with these NHL will succumb to disease progression within 2 years of ...
Tycel Phillips +2 more
doaj +2 more sources
Russian Open Medical Journal, 2020 The article is dedicated to contemporary views on the change of endothelial function in the patients with lymphoproliferative disorders prior to, and in the process of, chemotherapeutic treatment. Considering that possibilities of standard examination do
Igor L. Davydkin +7 more
doaj +2 more sources
CD30+ lymphoproliferative disorders [PDF]
Haematologica, 2010 CD30 antigen, originally identified as a cell surface marker of the malignant Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin’s lymphoma by the use of the Ki-1 monoclonal antibody, is a transmembrane glycoprotein member of the tumor necrosis factor (TNF) receptor superfamily.[1][1] In ...
Laurence de Leval, Philippe Gaulard
doaj +3 more sources